Shifamed
Overview
Shifamed is a medical technology innovation hub that develops devices and incubates entire companies around them, from concept through clinical testing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Supira Medical | Nov 2023 | Series D | Co-investor |
| Akura Medical | Oct 2023 | Series B | Co-investor |
| Adona Medical | Apr 2022 | Series B | Co-investor |
| Tioga Cardiovascular | Feb 2023 | Series C | Co-investor |
| Myra Vision | Jun 2023 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Shifamed based?
Shifamed is headquartered in Campbell, California, United States.
When was Shifamed founded?
Shifamed was founded in 2007.
How many portfolio companies does Shifamed have?
Shifamed has 7 portfolio companies in Caplight's dataset.
What are some companies in Shifamed's portfolio?
Portfolio companies visible on Caplight include Supira Medical, Akura Medical, Adona Medical, Tioga Cardiovascular, Myra Vision.
What was Shifamed's most recent investment shown here?
Shifamed's most recent investment in this portfolio sample was in Supira Medical in 2023.
What sectors does Shifamed focus on?
Shifamed focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Shifamed focus on?
Shifamed typically invests at the MultiStage stage.
What is Shifamed's AUM?
Shifamed's assets under management are estimated between $100.0M and $250.0M.